Positive Results for Lipid inCode® in NHS Clinical Study
15 févr. 2022 02h00 HE
|
GENinCode Plc
OXFORD, England, Feb. 15, 2022 (GLOBE NEWSWIRE) -- GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the successful completion...
FDA Pre-Submission Filed for Cardio inCode-SCORE
11 janv. 2022 02h30 HE
|
GENinCode Plc
OXFORD, England, Jan. 11, 2022 (GLOBE NEWSWIRE) -- GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the filing of its...